Argenx
ARGX
$398.81
Share price
1.28%
Change (1 day)
-1.77%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Argenx (ARGX) Fails to deliver data
Key failure to deliver metrics for Argenx :
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $1.15 M
- Last 3 months FTD volume: $13.2 M
- Last year FTD volume: $28.33 M
Failures to deliver for Argenx (ARGX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Argenx (ARGX) - since 2017
Volume in USD (price x number of shares), data since 2017Argenx (ARGX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $13.28 M | -29.31% |
| 2023 | $18.79 M | -94.36% |
| 2022 | $0.33 B | 866.49% |
| 2021 | $34.48 M | 44.9% |
| 2020 | $23.79 M | -7.86% |
| 2019 | $25.82 M | 75.29% |
| 2018 | $14.73 M | -48.76% |
| 2017 | $28.75 M |